ホーム › がん（全種類） › バージニア › Arlington
Arlington、VAにおけるがん（全種類）の臨床試験
Arlingtonとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する48件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
被験者募集中第3相
- Inova Schar Cancer Institute, Fairfax · 11マイル先
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第2/3相
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · 11マイル先
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
被験者募集中第1/2相
- NEXT Virginia, Fairfax · 11マイル先
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
被験者募集中第2相
- Virginia Cancer Specialists ( Site 1102), Fairfax · 11マイル先
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
被験者募集中第2相
- Next Virginia /ID# 279684, Fairfax · 11マイル先
A Study of ASP3082 in Adults With Advanced Solid Tumors
被験者募集中第1相
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11マイル先
REC-7735 in Participants With Solid Tumors
被験者募集中第1/2相
- NEXT Virginia, Fairfax · 11マイル先
A Study of PHN-012 in Patients With Advanced Solid Tumors
被験者募集中第1相
- PHN-012-001 Site, Fairfax · 11マイル先
Registry Study for Radiation Therapy Outcomes
被験者募集中観察研究
- Inova Schar Cancer Institute, Fairfax · 11マイル先
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
被験者募集中第1相
- NEXT Oncology, Fairfax · 11マイル先
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
被験者募集中第3相
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11マイル先
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
被験者募集中第3相
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · 11マイル先
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Inova Schar Cancer Institute, Fairfax · 11マイル先
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- NEXT Oncology Virginia, Fairfax · 11マイル先
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
被験者募集中第1相
- NEXT Virginia ( Site 0054), Fairfax · 11マイル先
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
被験者募集中第1相
- Investigational Site number: 404, Fairfax · 11マイル先
A Phase 1/1b Study of IAM1363 in HER2 Cancers
被験者募集中第1相
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11マイル先
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
被験者募集中第1相
- NEXT Oncology, Fairfax · 11マイル先
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- USO - Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
被験者募集中第1相
- NEXT Oncology, Fairfax · 11マイル先
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Inova Fairfax Hospital, Falls Church · 4マイル先
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
被験者募集中第1相
- NEXT Oncology Virginia, Fairfax · 11マイル先
A Study of ASP1002 in Adults for Treatment of Solid Tumors
被験者募集中第1相
- NEXT Oncology Virginia, Fairfax · 11マイル先
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
被験者募集中第2相
- 522, Fairfax · 11マイル先
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第1相
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11マイル先
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
被験者募集中第2相
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11マイル先
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11マイル先
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- USO-Virginia Cancer Specialists, PC, Fairfax · 11マイル先
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
被験者募集中健康なボランティア歓迎
- Inova Schar Cancer Institute, Fairfax · 11マイル先
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
被験者募集中第1/2相
- NEXT Oncology Virginia, Fairfax · 11マイル先
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- NEXT, Fairfax · 11マイル先
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
被験者募集中
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · 11マイル先
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
被験者募集中第1相
- Research Site, Fairfax · 11マイル先
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
被験者募集中第1相
- NEXT Oncology Virginia, Fairfax · 11マイル先
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
被験者募集中第1/2相
- NEXT Virginia, Fairfax · 11マイル先
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
被験者募集中第1相
- NEXT Oncology - Virginia, Fairfax · 11マイル先
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
被験者募集中第1相
- NEXT Oncology Virginia, Fairfax · 11マイル先
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
被験者募集中第1/2相
- NEXT Oncology, Fairfax · 11マイル先
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
被験者募集中第1相
- NEXT Virigina, Fairfax · 11マイル先
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
被験者募集中第1/2相
- NEXT Virginia, Fairfax · 11マイル先
A Study in Patients With Advanced Cancers
被験者募集中第1/2相
- NEXT Oncology Virginia, Fairfax · 11マイル先
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- New York City, NY109件の研究
- Boston, MA85件の研究
- Los Angeles, CA74件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Washington, DC58件の研究
- Durham, NC58件の研究
- Chicago, IL51件の研究
- Atlanta, GA49件の研究
- Seattle, WA49件の研究
- St. Louis, MO46件の研究
Arlingtonにおける他の研究
- 非小細胞肺癌104件の研究
- 転移性癌53件の研究
- 大腸癌52件の研究
- 乳がん47件の研究
- 卵巣がん46件の研究
- 肺がん41件の研究
- 子宮内膜がん39件の研究
- 膵臓がん33件の研究
- 頭頸部扁平上皮癌26件の研究
- 小細胞肺がん23件の研究
- 胃癌20件の研究
- トリプルネガティブ乳がん20件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。